Global Rodenticides Market will reach USD 1004.72 Million

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Global Rodenticides Market will reach USD 1004.72 Million by 2021: By Type, Application, End User and Products

Sarasota, FL, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Rodenticides Market by Type (Non Anticoagulant, Anticoagulant, and Others) for Agriculture, Pest Control, Warehouses and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021” . According to the report, global demand for  rodenticides market was valued at over USD 723.86 million in 2015, is expected to reach above USD 1004.72 million in 2021 and is anticipated to grow at a CAGR of slightly above 5.6% between 2016 and 2021.  

In 2015, the rodenticides market was dominated by North America. The factors contributing to the high demand of rodenticides are government initiatives for cultivating high-quality food. This is mainly due to rapidly decreasing plowable land in this region. U.S accounted for the largest market share in this. Other factors such as growing demand for bio rodenticides in North America contribute to the growth of rodenticides market.

Browse through 32 Market Tables and 31 Figures spread over 110 Pages and in-depth TOC on “Global Rodenticides Market: By Type, Application, End User, Products, Industry Size, Share, Trends and Forecast 2015-2021”.

Request free Sample of this Report @ https://www.zionmarketresearch.com/sample/rod...des-market

The rodenticides market in Europe has had a stagnant growth in the past few years owing to strict regulations passed by the European government on the use of rodenticides. However, in recent times, low concentrated rodenticides that are less harmful are being introduced in the European market which is expected to drive the rodenticides market growth in this region.

Asia Pacific is expected to be the fastest growing market in 2015 for the rodenticides and is predicted to gain traction over the forecast period. Rapidly growing agricultural sector in India and China contributes to the high growth of rodenticides in Asia Pacific. Increasing accomplishment from the government for improving the productivity and quality of food is expected to spur the growth of rodenticides market. There has been tremendous growth in infrastructure sector in China and India which has led to shrinkage of arable land. Consequently, to assure the food requirement advance technologies are followed which in turn may assist the growth of rodenticides in Asia Pacific. In addition, demand for pesticides is growing extensively in Asia Pacific due to increasing population. Fewer regulations imposed by the governing bodies of India and China for utilization of pesticides in this region have forced the players to set up their plants in these regions. This factor is anticipated to boost the rodenticides market in the forecast period. Furthermore, agricultural is considered as the main livelihood in majority part of India, which prompts the use of various pesticides for getting the higher yield. Also, pesticides are mainly used for improving the productivity of crops to obtain high profit is estimated to augment the growth of rodenticides market.

Browse the full " Rodenticides Market by Type (Non Anticoagulant, Anticoagulant, and Others) for Agriculture, Pest Control, Warehouses and Other Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021 " report at  https://www.zionmarketresearch.com/report/rod...des-market

Latin America is expected to experience robust growth for rodenticides market in the near future due to increasing agricultural sector in Brazil. Growing population and high use of pesticides for achieve better productivity is likely to trigger the growth of rodenticides market in this region. The Middle East and Africa is anticipated to show sustainable growth in the near future due to high consumption of several pesticides. In addition, rapidly increasing agricultural sector due to an existence of huge arable land aids the rodenticides market growth.

Some of the key participants in the rodenticides market include The DOW Chemical Company, Syngenta AG, UPL Limited, Pelgar International, Senestech, Inc, Bayer Cropscience AG, BASF SE, Liphatech, Inc., Neogen Corporation, E.I. Du Pont De Nemours and Company, J.T. Eaton & Co., Inc and Impex Europa S.L Due to various regulations imposed by the governing bodies the players primarily focus on R&D for innovating eco-friendly rodenticides.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/ro...des-market

This report segments the rodenticides market as follows: Rodenticides Market: Type Segment Analysis

  • Non-anticoagulant rodenticides
    • Cholecalciferol
    • Bromethalin
    • Zinc Phosphide
  • Anticoagulant rodenticides
    • Diphacinone
    • Warfarin
    • Chlorophacinone
    • Coumatetralyl 
    • Difenacoum
    • Brodifacoum
    • Flocoumafen
    • Bromadiolone
    • Difethialone
  • Others

Rodenticides Market: Applications Segment Analysis

  • Agricultural
  • Pest control
  • Warehouses
  • Others

Related Reports:

Rodenticides Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany 
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

      

Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/...des-market   

About Us

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 180

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 410

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 298

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 317

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 343

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 229

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Fabhalta® Breakthrough in PNH Treatment Showcased

Updated Category News Views 290

Novartis Fabhalta® Achieves Significant Hemoglobin Improvements In recent studies, Novartis has showcased promising results from its Phase IIIB APPULSE-PNH study regarding Fabhalta (iptacopan), designed for adult patients suffering from paroxysmal nocturnal hemoglobinuria (PNH). Patients who switched from anti-C5 therapies demonstrated noteworthy improvement in their...

Continue Reading
Insights into Indonesia's Economic Landscape for Credit Investors

Updated Category News Views 208

Understanding Indonesia's Market Dynamics This week, Gimme Credit unveiled a new Indonesia Country Report that delves into the recent fluctuations in the equity market and its potential ripple effects on foreign exchange and bond markets. The inquiry raises fundamental questions about whether these shifts could necessitate a higher risk premium for those investing in...

Continue Reading
Pliant Therapeutics to Showcase Innovations at Key Healthcare Conference

Updated Category News Views 187

Introduction to Pliant Therapeutics' Participation Pliant Therapeutics, Inc. (NASDAQ: PLRX), a dedicated force in the clinical-stage biotechnology sector, is set to make waves at an upcoming healthcare conference. The event serves as a platform for the company to showcase its integrin-based therapeutics—game-changing innovations aimed at treating various serious health...

Continue Reading
OSB Group PLC Financial Performance Overview for 2025

Updated Category News Views 322

OSB Group PLC Trading Update Summary OSB GROUP PLC, a specialist lending and retail savings group, is pleased to share its trading update for the nine-month period concluding on 30 September 2025. This report highlights the Group's steady growth and enhanced financial performance in line with expectations and strategic objectives. Performance Insights for the Nine-Month...

Continue Reading
Toll Brothers Unveils Luxurious Homes at Ridge Pointe Estates

Updated Category News Views 222

Toll Brothers Unveils New Luxury Homes at Ridge Pointe Estates Toll Brothers, Inc. (NYSE: TOL), recognized as a leader in the luxury home construction industry, has introduced its latest community, Ridge Pointe Estates. This community, now officially open, offers prospective homeowners a blend of elegance and modern living. Located within a serene setting, Ridge Pointe...

Continue Reading